BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moore MM, Schoeny RS, Becker RA, White K, Pottenger LH. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Crit Rev Toxicol 2018;48:312-37. [PMID: 29431554 DOI: 10.1080/10408444.2017.1423462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kobets T, Duan JD, Vock E, Deschl U, Williams GM. Evaluation of Pharmaceuticals for DNA Damage in the Chicken Egg Genotoxicity Assay (CEGA). Int J Toxicol 2022;:10915818221093583. [PMID: 35658642 DOI: 10.1177/10915818221093583] [Reference Citation Analysis]
2 Lu K, Hsiao YC, Liu CW, Schoeny R, Gentry R, Starr TB. A Review of Stable Isotope Labeling and Mass Spectrometry Methods to Distinguish Exogenous from Endogenous DNA Adducts and Improve Dose-Response Assessments. Chem Res Toxicol 2021. [PMID: 34910474 DOI: 10.1021/acs.chemrestox.1c00212] [Reference Citation Analysis]
3 Kazmi I, Al-Abbasi FA, Afzal M, Altayb HN, Nadeem MS, Gupta G. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021;13:2086. [PMID: 34959368 DOI: 10.3390/pharmaceutics13122086] [Reference Citation Analysis]
4 LeBaron MJ, Hotchkiss JA, Zhang F, Koehler MW, Boverhof DR. Investigation of potential early key events and mode of action for 1,2-dichloroethane-induced mammary tumors in female rats. J Appl Toxicol 2021;41:362-74. [PMID: 32830330 DOI: 10.1002/jat.4048] [Reference Citation Analysis]
5 Schrenk D, Bignami M, Bodin L, Chipman JK, Del Mazo J, Grasl-Kraupp B, Hogstrand C, Hoogenboom LR, Leblanc JC, Nebbia CS, Nielsen E, Ntzani E, Petersen A, Sand S, Schwerdtle T, Vleminckx C, Marko D, Oswald IP, Piersma A, Routledge M, Schlatter J, Baert K, Gergelova P, Wallace H; EFSA Panel on Contaminants in the Food Chain (CONTAM). Risk assessment of aflatoxins in food. EFSA J 2020;18:e06040. [PMID: 32874256 DOI: 10.2903/j.efsa.2020.6040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
6 Wang J, Li CD, Sun L. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma. Biomolecules 2020;10:E301. [PMID: 32075046 DOI: 10.3390/biom10020301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Klapacz J, Gollapudi BB. Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment. Environ Mol Mutagen 2020;61:84-93. [PMID: 31301246 DOI: 10.1002/em.22318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Liu X, Fan D, Duan S, Bao C, Wang H, Wang X, Sun X, Wei Q. An ultrasensitive label-free photoelectrochemical sensor based on Ag 2 O-sensitized WO 3 /TiO 2 acicular composite for AFB1 detection. Anal Methods 2019;11:3890-7. [DOI: 10.1039/c9ay01277j] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pottenger LH, Boysen G, Brown K, Cadet J, Fuchs RP, Johnson GE, Swenberg JA. Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions. Environ Mol Mutagen 2019;60:100-21. [PMID: 30536466 DOI: 10.1002/em.22248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
10 Kang DS, Yang JH, Kim HS, Koo BK, Lee CM, Ahn YS, Jung JH, Seo YR. Application of the Adverse Outcome Pathway Framework to Risk Assessment for Predicting Carcinogenicity of Chemicals. J Cancer Prev 2018;23:126-33. [PMID: 30370257 DOI: 10.15430/JCP.2018.23.3.126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]